Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells
| Autor: | Baosan Han, Gang-Ming Zou, Zhihua Chen, Haimei Tang, Miaofeng Zhang, Shaojie Jiang, Jian Fei, Lina Zhu |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Cancer Research
Biology Imides medicine.disease_cause Cyclin D1 Downregulation and upregulation Cell Line Tumor Pancreatic cancer Benzoquinones DNA-(Apurinic or Apyrimidinic Site) Lyase medicine Humans Wnt Signaling Pathway Cell Proliferation Oncogene Wnt signaling pathway Hydrogen Peroxide Cell cycle medicine.disease Cell biology Gene Expression Regulation Neoplastic Pancreatic Neoplasms Oncology Gene Knockdown Techniques Cancer cell Quinolines Propionates Reactive Oxygen Species Oxidative stress |
| Zdroj: | International Journal of Oncology. 47:610-620 |
| ISSN: | 1791-2423 1019-6439 |
| DOI: | 10.3892/ijo.2015.3048 |
| Popis: | Apurinic/apyrimidinic endonuclease 1/redox factor-1 (Ape1/Ref-1, Ape1) is a multifunctional protein that is upregulated in human pancreatic cancer. Ape1 redox domain plays an essential role in regulating the effects of reactive oxygen species (ROS) generated during physiological metabolism and pathological stress. In the present study, we explored whether Ape1 and ROS affect WNT/β-catenin signaling. We used E3330, a small molecule inhibitor of the redox activity of Ape1, and a siRNA approach to knock down Ape1, in two human pancreatic cancer cell lines. Inhibition of Ape1 resulted in growth suppression of pancreatic cancer cells, increased ROS levels, upregulation of β-catenin and c-myc and downregulation of cyclin D1. Consistent with these data, overexpression of Ape1 in pancreatic cancer cells reduced ROS and c-myc levels and increased cyclin D1 levels. Moreover, treatment of pancreatic cancer cells with H2O2 to induce oxidative stress resulted in upregulated ROS levels, decreased Ape1 at both the mRNA and protein level, and alterations in WNT/β-catenin pathway components. Finally, treatment of pancreatic cancer cells with the WNT/β-catenin inhibitor IWR-1 resulted in growth inhibition, which was greatly enhanced when combined with E3330 treatment. In summary, our results demonstrate that ROS is an important intracellular messenger that can modulate WNT/β‑catenin signaling. The present study provides interesting new insight into crosstalk between the redox function of Ape1 and WNT/β-catenin signaling in cancer cells. Furthermore, our data show that the combination of Ape1 and WNT inhibitors enhanced the inhibition of pancreatic cell proliferation. These results provide a promising novel therapeutic strategy for treating pancreatic cancer in future. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|